SCHEMBL30842003

SCHEMBL30842003

CCOCc1ccc(CNC(=O)N(C)CC2CCN(CC(=O)c3ccc(F)cc3)CC2)cn1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 4/20 0.42
KCNH2 Q12809 3/20 0.42
HTR2A P28223 9/20 0.41
CYP1A2 P05177 2/20 0.39
CYP2C19 P33261 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CYP3A4 P08684 1/20 0.39
GAA P10253 1/20 0.39
CYP2D6 P10635 1/20 0.39
PKM P14618 1/20 0.39
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
HTR2C P28335 1/20 0.38
HTR2B P41595 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL29207990 0.95 KCNH2 (0.39) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30842099 0.92 HTR2A (0.42) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30832020 0.88 ALDH1A1 (0.42) HRH3KCNH2HTR2ACYP1A2CYP2C19
Trifluoroacetic Acid SCHEMBL29208087 0.88 HTR2A (0.41) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30842023 0.87 HTR2A (0.41) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30831998 0.86 HRH3 (0.42) HRH3KCNH2HTR2AALDH1A1TSHR
SCHEMBL30832023 0.85 MLLT1 (0.43) HRH3KCNH2HTR2AALDH1A1TSHR
SCHEMBL30842010 0.84 ALDH1A1 (0.41) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30832039 0.84 ALDH1A1 (0.54) HRH3KCNH2HTR2ACYP1A2CYP2C19
SCHEMBL30832012 0.82 HTR2A (0.46) HRH3KCNH2HTR2ATSHRHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024067304-A1 COMPOUND WITH INHIBITORY ACTIVITY AGAINST SIGMA2 AND 5HT2A AND USE 瀚远医药有限公司 2024-04-04 WO disclosed